IMI Consulting is Europe’s leading Management Consultancy and Advisory in Life Sciences having a track-record of over 30 years in servicing its clients. Because of IMI’s 150 Associate Partner network, it provides most forms of transaction and therapeutic expertise on a worldwide basis:
· Strategy Development (market intelligence, development of new ways to
compete, pipeline and segment analysis
· Market Access and Pricing, Strategic Plans and Planning, etc.)
· Transaction Support (usually as implementation of the strategy, BD&L, Mergers &
Acquisitions including spin-outs )
· Capital Raising. IMI raises capital from seed to Round C, from VCs to private
investors (HNW-angels).
Its 150 Associate Partner base allows specialization in most therapeutic sectors servicing Big & Specialty Pharma, Biotech, Diagnostic, MedTech, e-health and OTC/Nutritionals:
Addiction, Analgesics/Rheumatoid Arthritis, Cancer, Cardiovascular, CNS, Dermatology, Devices, Endocrinology, Gynecology, Gastrointestinal, Hematology, Life-Cycle Management, Metabolic, Molecular Diagnostics, Respiratory, Robotics, Genetic Editing, Nutritionals, OTCs, Transplantation, Urology, etc.
We cover all of Europe, USA and Asia.
Industry
Business Consulting and Services, Company ratings, Business Consultancy, Business Services, Electronic data processing - software, Unternehmensberatung, Pharma-Marketing, Unternehmensberatung für das Gesundheitswesen, Unternehmensberatung, kaufmännische, Marketing für das Gesundheitswesen
HQ Location
Wietze Aue 71
Wedemark, Lower Saxony 30900, DE
Keywords
BD&LMergers & AcquisitionsValuationsLife-Science Strategic ServicesMarket Access and Pricingand and all forms of Capital Raising